SMCs With LVH Compared to HCM

NCT07006974 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 165

Last updated 2026-01-08

No results posted yet for this study

Summary

The goal of this cohort study is to investigate the clinical characteristics of SMCs and to explore the difference in cardiovascular outcomes in comparison to age-, sex-, and admission year-matched HCM patients. The main question it aims to answer is:

* Do patients with SMCs have higher rates of cardiac outcomes?
* What risk factors do SMCs patients experience a poor prognosis?

Conditions

  • Syndromic and Metabolic Cardiomyopathy
  • Cardiomyopathies

Interventions

OTHER

SMCs

patients with SMCs

Sponsors & Collaborators

  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Principal Investigators

  • Liang · Chinese Academy of Medical Sciences, Fuwai Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-05-27
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07006974 on ClinicalTrials.gov